Ekso Bionics Holdings, Inc. Common Stock
NASDAQ:CHRNMedical - Specialties
+$2.44 today
- Market cap
- $51.24M
- Beta
- 1.03
Volume 0.12M
Average 0.22M
Returns on capital
Ekso Bionics Holdings, Inc. Common Stock management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
No return metrics data available.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Raj Jegannathan | Chief Technology Officer | — | — | — | — |
Lawrence Lam | Chief Product Officer | — | — | — | — |
Thomas Jorgensen | Senior Vice President of Marketing | — | — | — | — |
Jerome Wong | Chief Financial Officer | — | 52 | 364.77K | 10.24% |
Ying Cenly Chen | CEO & Director | — | — | 2.80M | 78.58% |
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Aug 16, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
No open-market purchases or sales in the last 12 months.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
Competitors
Who does Ekso Bionics Holdings, Inc. Common Stock compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
No competitor data available.
Questions
Management questions
Common questions about CHRN's management, answered from reported figures.
Who manages CHRN?
Ekso Bionics Holdings, Inc. Common Stock (CHRN) lists 5 active executives. The top listed executive is Raj Jegannathan, Chief Technology Officer.
Are CHRN insiders buying or selling?
Recent insider activity shows net buying of $0.00.
Continue the stock analysis
Jump to another research area for this company.